TY - JOUR PY - 2005 DA - 2005// TI - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66544-0 DO - 10.1016/S0140-6736(05)66544-0 ID - ref1 ER - TY - JOUR AU - Davies, C. AU - Godwin, J. AU - Gray, R. AU - Clarke, M. AU - Cutter, D. AU - Darby, S. AU - McGale, P. AU - Pan, H. C. AU - Taylor, C. AU - Wang, Y. C. AU - Dowsett, M. AU - Ingle, J. AU - Peto, R. PY - 2011 DA - 2011// TI - Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)60993-8 DO - 10.1016/S0140-6736(11)60993-8 ID - Davies2011 ER - TY - JOUR AU - van Leeuwen, F. E. AU - Benraadt, J. AU - Coebergh, J. W. AU - Kiemeney, L. A. AU - Gimbrere, C. H. AU - Otter, R. AU - Schouten, L. J. AU - Damhuis, R. A. AU - Bontenbal, M. AU - Diepenhorst, F. W. PY - 1994 DA - 1994// TI - Risk of endometrial cancer after tamoxifen treatment of breast cancer JO - Lancet VL - 343 UR - https://doi.org/10.1016/S0140-6736(94)92692-1 DO - 10.1016/S0140-6736(94)92692-1 ID - van Leeuwen1994 ER - TY - JOUR AU - Bernstein, L. AU - Deapen, D. AU - Cerhan, J. R. AU - Schwartz, S. M. AU - Liff, J. AU - McGann-Maloney, E. AU - Perlman, J. A. AU - Ford, L. PY - 1999 DA - 1999// TI - Tamoxifen therapy for breast cancer and endometrial cancer risk JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.19.1654 DO - 10.1093/jnci/91.19.1654 ID - Bernstein1999 ER - TY - JOUR AU - Swerdlow, A. J. AU - Jones, M. E. PY - 2005 DA - 2005// TI - Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji057 DO - 10.1093/jnci/dji057 ID - Swerdlow2005 ER - TY - JOUR AU - Bergman, L. AU - Beelen, M. L. AU - Gallee, M. P. AU - Hollema, H. AU - Benraadt, J. AU - van Leeuwen, F. E. PY - 2000 DA - 2000// TI - Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02677-5 DO - 10.1016/S0140-6736(00)02677-5 ID - Bergman2000 ER - TY - JOUR PY - 1996 DA - 1996// JO - IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Some pharmaceutical drugs: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans which met in Lyon, 13-20 February 1996 lARC monographs on the evaluation of carcinogenic risks to humans VL - 66 ID - ref7 ER - TY - JOUR AU - Curtis, R. E. AU - Freedman, D. M. AU - Sherman, M. E. AU - Fraumeni, J. F. PY - 2004 DA - 2004// TI - Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh007 DO - 10.1093/jnci/djh007 ID - Curtis2004 ER - TY - JOUR AU - Bland, A. E. AU - Calingaert, B. AU - Secord, A. A. AU - Lee, P. S. AU - Valea, F. A. AU - Berchuck, A. AU - Soper, J. T. AU - Havrilesky, L. PY - 2009 DA - 2009// TI - Relationship between tamoxifen use and high risk endometrial cancer histologic types JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.08.035 DO - 10.1016/j.ygyno.2008.08.035 ID - Bland2009 ER - TY - JOUR AU - Acharya, S. AU - Hensley, M. L. AU - Montag, A. C. AU - Fleming, G. F. PY - 2005 DA - 2005// TI - Rare uterine cancers JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70463-0 DO - 10.1016/S1470-2045(05)70463-0 ID - Acharya2005 ER - TY - JOUR AU - Lasset, C. AU - Mignotte, H. AU - Bonadona, V. AU - Chauvin, F. PY - 1998 DA - 1998// TI - Prognosis of tamoxifen-associated endometrial cancer JO - J Clin Oncol VL - 16 ID - Lasset1998 ER - TY - JOUR AU - Hoogendoorn, W. E. AU - Hollema, H. AU - van Boven, H. H. AU - Bergman, E. AU - de Leeuw-Mantel, G. AU - Platteel, I. AU - Fles, R. AU - Nederlof, P. M. AU - Mourits, M. J. AU - van Leeuwen, F. E. PY - 2008 DA - 2008// TI - Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer JO - Breast Cancer Res Treat VL - 112 UR - https://doi.org/10.1007/s10549-007-9823-1 DO - 10.1007/s10549-007-9823-1 ID - Hoogendoorn2008 ER - TY - JOUR AU - Fisher, B. AU - Costantino, J. P. AU - Redmond, C. K. AU - Fisher, E. R. AU - Wickerham, D. L. AU - Cronin, W. M. PY - 1994 DA - 1994// TI - Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 JO - J Natl Cancer Inst VL - 86 UR - https://doi.org/10.1093/jnci/86.7.527 DO - 10.1093/jnci/86.7.527 ID - Fisher1994 ER - TY - STD TI - ACOG committee opinion. No. 336: Tamoxifen and uterine cancer. Obstet Gynecol. 2006, 107: 1475-1478. 10.1097/00006250-200606000-00057. ID - ref14 ER - TY - JOUR AU - Vogel, V. G. AU - Costantino, J. P. AU - Wickerham, D. L. AU - Cronin, W. M. AU - Cecchini, R. S. AU - Atkins, J. N. AU - Bevers, T. B. AU - Fehrenbacher, L. AU - Pajon, E. R. AU - Wade, J. L. AU - Robidoux, A. AU - Margolese, R. G. AU - James, J. AU - Runowicz, C. D. AU - Ganz, P. A. AU - Reis, S. E. AU - McCaskill-Stevens, W. AU - Ford, L. G. AU - Jordan, V. C. AU - Wolmark, N. PY - 2010 DA - 2010// TI - Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancer JO - Cancer Prev Res (Phila) VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0076 DO - 10.1158/1940-6207.CAPR-10-0076 ID - Vogel2010 ER - TY - JOUR AU - Fles, R. AU - Hoogendoorn, W. E. AU - Platteel, I. AU - Scheerman, C. E. AU - de Leeuw-Mantel, G. AU - Mourits, M. J. AU - Hollema, H. AU - van Leeuwen, F. E. AU - van Boven, H. H. AU - Nederlof, P. M. PY - 2010 DA - 2010// TI - Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure JO - Genes Chromosomes Cancer VL - 49 UR - https://doi.org/10.1002/gcc.20781 DO - 10.1002/gcc.20781 ID - Fles2010 ER - TY - STD TI - Centraal Bureau voor de Statistiek. [http://www.cbs.nl] UR - http://www.cbs.nl ID - ref17 ER - TY - JOUR AU - Hawkins, M. M. AU - Swerdlow, A. J. PY - 1992 DA - 1992// TI - Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales JO - Br J Cancer VL - 66 UR - https://doi.org/10.1038/bjc.1992.279 DO - 10.1038/bjc.1992.279 ID - Hawkins1992 ER - TY - JOUR AU - Hermansen, S. W. AU - Leitzmann, M. F. AU - Schatzkin, A. PY - 2009 DA - 2009// TI - The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality JO - Am J Epidemiol VL - 169 UR - https://doi.org/10.1093/aje/kwn404 DO - 10.1093/aje/kwn404 ID - Hermansen2009 ER - TY - BOOK AU - Armitage, P. AU - Berry, G. PY - 1987 DA - 1987// TI - Statistical Methods in Medical Research PB - Blackwell Scientific Publications CY - Oxford ID - Armitage1987 ER - TY - JOUR AU - Zou, G. PY - 2004 DA - 2004// TI - A modified poisson regression approach to prospective studies with binary data JO - Am J Epidemiol VL - 159 UR - https://doi.org/10.1093/aje/kwh090 DO - 10.1093/aje/kwh090 ID - Zou2004 ER - TY - BOOK AU - Clayton, D. AU - Hills, M. PY - 1993 DA - 1993// TI - Statistical Methods in Epidemiology PB - Oxford University Press CY - Oxford ID - Clayton1993 ER - TY - CHAP PY - 2007 DA - 2007// TI - Stata Statistical Software: Release 10 BT - Book Stata Statistical Software: Release 10 ID - ref23 ER - TY - JOUR AU - Runowicz, C. D. AU - Costantino, J. P. AU - Wickerham, D. L. AU - Cecchini, R. S. AU - Cronin, W. M. AU - Ford, L. G. AU - Vogel, V. G. AU - Wolmark, N. PY - 2011 DA - 2011// TI - Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR) JO - Am J Obstet Gynecol VL - 205 UR - https://doi.org/10.1016/j.ajog.2011.06.067 DO - 10.1016/j.ajog.2011.06.067 ID - Runowicz2011 ER - TY - JOUR AU - Prasad, M. AU - Wang, H. AU - Douglas, W. AU - Barakat, R. R. AU - Ellenson, L. H. PY - 2005 DA - 2005// TI - Molecular genetic characterization of tamoxifen-associated endometrial cancer JO - Gynecol Oncol VL - 96 UR - https://doi.org/10.1016/j.ygyno.2004.08.046 DO - 10.1016/j.ygyno.2004.08.046 ID - Prasad2005 ER - TY - JOUR AU - Ferguson, S. E. AU - Olshen, A. B. AU - Viale, A. AU - Awtrey, C. S. AU - Barakat, R. R. AU - Boyd, J. PY - 2004 DA - 2004// TI - Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma JO - Gynecol Oncol VL - 92 UR - https://doi.org/10.1016/j.ygyno.2003.10.038 DO - 10.1016/j.ygyno.2003.10.038 ID - Ferguson2004 ER - TY - JOUR AU - Sant, M. AU - Allemani, C. AU - Santaquilani, M. AU - Knijn, A. AU - Marchesi, F. AU - Capocaccia, R. PY - 2009 DA - 2009// TI - EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.11.018 DO - 10.1016/j.ejca.2008.11.018 ID - Sant2009 ER - TY - CHAP AU - Kosary, C. ED - Ries, L. A. G. ED - Young, J. L. ED - Keel, G. E. ED - Eisner, M. P. ED - Lin, Y. D. ED - Horner, M. -. J. PY - 2007 DA - 2007// TI - Cancer of the corpus uteri BT - SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics Volume NIH Pub. No. 07-6215 PB - National Cancer Institute CY - Bethesda, MD ID - Kosary2007 ER - TY - JOUR AU - Fornander, T. AU - Rutqvist, L. E. AU - Cedermark, B. AU - Glas, U. AU - Mattsson, A. AU - Silfversward, C. AU - Skoog, L. AU - Somell, A. AU - Theve, T. AU - Wilking, N. PY - 1989 DA - 1989// TI - Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(89)91141-0 DO - 10.1016/S0140-6736(89)91141-0 ID - Fornander1989 ER -